{"nct_id":"NCT02431247","title":"A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2015-07-06","start_date_type":"ACTUAL","primary_completion_date":"2017-03-02","primary_completion_date_type":"ACTUAL","completion_date":"2020-09-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}